NCT00325169View on ClinicalTrials.gov

SERETIDE Plus Tiotropium Versus Individual Components

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium + SERETIDE 50/500

Trial Locations (5)

9000

GSK Investigational Site, Ghent

SO16 6YD

GSK Investigational Site, Southampton

M23 9LT

GSK Investigational Site, Manchester

NW3 2QG

GSK Investigational Site, London

SE5 9RJ

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY